Testing effectiveness (Phase 2)Ended earlyNCT01465386
What this trial is testing
Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission
Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Myeloblastic Leukemia Without Maturation (M1)+9 more
Fred Hutchinson Cancer Center 6